The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region

Monoclonal antibody (MAb) treatments have been safe and effective in averting severe Covid-19 infections when given early, but supplies have been scarce. Intermountain Healthcare used its supply to maximum effect across its broad geographic footprint by identifying patients at highest risk and deliv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakata, Theadora, Brunisholz, Kim D., Andersen, Curtis, Davie, Daniel, Srivastava, Rajendu, Webb, Brandon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372990/
http://dx.doi.org/10.1056/CAT.21.0154
_version_ 1783739869077438464
author Sakata, Theadora
Brunisholz, Kim D.
Andersen, Curtis
Davie, Daniel
Srivastava, Rajendu
Webb, Brandon J.
author_facet Sakata, Theadora
Brunisholz, Kim D.
Andersen, Curtis
Davie, Daniel
Srivastava, Rajendu
Webb, Brandon J.
author_sort Sakata, Theadora
collection PubMed
description Monoclonal antibody (MAb) treatments have been safe and effective in averting severe Covid-19 infections when given early, but supplies have been scarce. Intermountain Healthcare used its supply to maximum effect across its broad geographic footprint by identifying patients at highest risk and delivering them MAb therapy at the optimal time, saving lives and easing strain on hospitals.
format Online
Article
Text
id pubmed-8372990
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Massachusetts Medical Society
record_format MEDLINE/PubMed
spelling pubmed-83729902021-08-23 The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region Sakata, Theadora Brunisholz, Kim D. Andersen, Curtis Davie, Daniel Srivastava, Rajendu Webb, Brandon J. NEJM Catal Innov Care Deliv Case Study Monoclonal antibody (MAb) treatments have been safe and effective in averting severe Covid-19 infections when given early, but supplies have been scarce. Intermountain Healthcare used its supply to maximum effect across its broad geographic footprint by identifying patients at highest risk and delivering them MAb therapy at the optimal time, saving lives and easing strain on hospitals. Massachusetts Medical Society 2021-08-18 /pmc/articles/PMC8372990/ http://dx.doi.org/10.1056/CAT.21.0154 Text en Copyright © 2021 Massachusetts Medical Society. This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the Covid-19 pandemic or until revoked in writing. Upon expiration of these permissions, PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections.
spellingShingle Case Study
Sakata, Theadora
Brunisholz, Kim D.
Andersen, Curtis
Davie, Daniel
Srivastava, Rajendu
Webb, Brandon J.
The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
title The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
title_full The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
title_fullStr The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
title_full_unstemmed The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
title_short The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region
title_sort mab squad: delivering covid-19 monoclonal antibody therapy across a large geographic region
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372990/
http://dx.doi.org/10.1056/CAT.21.0154
work_keys_str_mv AT sakatatheadora themabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT brunisholzkimd themabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT andersencurtis themabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT daviedaniel themabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT srivastavarajendu themabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT webbbrandonj themabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT sakatatheadora mabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT brunisholzkimd mabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT andersencurtis mabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT daviedaniel mabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT srivastavarajendu mabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion
AT webbbrandonj mabsquaddeliveringcovid19monoclonalantibodytherapyacrossalargegeographicregion

Ejemplares similares